Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09NFW
|
|||
Former ID |
DIB005935
|
|||
Drug Name |
Dendritic cell vaccine
|
|||
Synonyms |
Dendritic cell vaccine, University of Bonn; Human telomerase reverse transcriptase (hTERT)-pulsed dendritic cells (cancer), University of Bonn
Click to Show/Hide
|
|||
Drug Type |
Vaccine
|
|||
Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1] | |
Company |
University of Bonn
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Telomerase reverse transcriptase (TERT) | Target Info | . | [2] |
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Validated targets of C-MYC transcriptional activation | |||
Regulation of Telomerase | ||||
IL2 signaling events mediated by PI3K | ||||
Regulation of nuclear beta catenin signaling and target gene transcription | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Formation of the beta-catenin:TCF transactivating complex |
References | Top | |||
---|---|---|---|---|
REF 1 | Dendritic cell-targeted vaccines--hope or hype. Nat Rev Immunol. 2014 Oct;14(10):705-11. | |||
REF 2 | In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells. J Immunotoxicol. 2009 Dec;6(4):243-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.